Clinical practice and outcome of radiotherapy for esophageal cancer between 1999 and 2003: The Japanese Radiation Oncology Study Group (JROSG) Survey

International Journal of Clinical Oncology

Volumn 17, Issue 1, 2012, Pages 48-54

  Nishimura, Yasumasa ^a   Koike, Ryuta ^a   Ogawa, Kazuhiko ^b   Sasamoto, Ryuta ^c   Murakami, Yuji ^d   Itoh, Yoshiyuki ^e   Negoro, Yoshiharu ^f   Itasaka, Satoshi ^g   Sakayauchi, Toru ^h   Tamamoto, Tetsuro ⁱ  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF THE RYUKYUS   (Japan)

^c NIIGATA UNIVERSITY MEDICAL AND DENTAL HOSPITAL   (Japan)

^d HIROSHIMA UNIVERSITY   (Japan)

^e NAGOYA UNIVERSITY   (Japan)

^f TENRI HOSPITAL   (Japan)

^g KYOTO UNIVERSITY   (Japan)

^h TOHOKU UNIVERSITY   (Japan)

ⁱ NARA MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Brachytherapy; Chemo radiation therapy; Esophageal cancer; National survey

Indexed keywords

CISPLATIN; FLUOROURACIL; NEDAPLATIN; ANTINEOPLASTIC AGENT; PLATINUM COMPLEX;

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL PRACTICE; CONTINUOUS INFUSION; CONTROLLED STUDY; DYSPHAGIA; ESOPHAGUS CANCER; ESOPHAGUS VARICES BLEEDING; HEART MUSCLE ISCHEMIA; HUMAN; INOPERABLE CANCER; JAPANESE; MAJOR CLINICAL STUDY; MULTIPLE CYCLE TREATMENT; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PERICARDIAL EFFUSION; PLEURA EFFUSION; PRIORITY JOURNAL; QUESTIONNAIRE; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIATION PNEUMONIA; BRACHYTHERAPY; CHEMORADIOTHERAPY; ESOPHAGUS TUMOR; JAPAN; MIDDLE AGED; PATHOLOGY; SQUAMOUS CELL CARCINOMA; SURVIVAL;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRACHYTHERAPY; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY; CISPLATIN; ESOPHAGEAL NEOPLASMS; FLUOROURACIL; HUMANS; JAPAN; MIDDLE AGED; ORGANOPLATINUM COMPOUNDS; QUESTIONNAIRES; RADIATION DOSAGE; SURVIVAL ANALYSIS;

EID: 84862281241     PISSN: 13419625     EISSN: 14377772     Source Type: Journal    
DOI: 10.1007/s10147-011-0254-y     Document Type: Article

References (27)

1. Al-Sarraf M, Herskovic A, Martz K et al (1997) Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: an intergroup study. J Clin Oncol 15:277-284
2. Cooper JS, Guo MD, Herskovic A et al (1999) Chemoradio-therapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group. JAMA 281:1623-1627
3. Smith TJ, Ryan LM, Douglass HO Jr et al (1998) Combined chemoradiotherapy vs. radiotherapy alone for early stage squa-mous cell carcinoma of the esophagus: a study of the Eastern Cooperative Oncology Group. Int J Radiat Oncol Biol Phys 42:269-276
4. Minsky BD, Pajak TF, Ginsberg RJetal(2002) INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy. J Clin Oncol 20:1167-1174
5. Nishimura Y, Suzuki M, Nakamatsu K et al (2002) Prospective trial of concurrent chemoradiotherapy with protracted infusion of 5-fluorouracil and cisplatin for T4 esophageal cancer with or without fistula. Int J Radiat Oncol Biol Phys 53:134-139
6. Ohtsu A, Boku N, Muro K et al (1999) Definitive chemoradio-therapy for T4 and/or M1 lymph node squamous cell carcinoma of the esophagus. J Clin Oncol 17:2915-2921
7. Sakai K, Inakoshi H, Sueyama H et al (1995) Concurrent radiotherapy and chemotherapy with protracted continuous infusion of 5-fluorouracil in inoperable esophageal squamous cell carcinoma. Int J Radiat Oncol Biol Phys 31:921-927
8. Hironaka S, Ohtsu A, Boku N et al (2003) Nonrandomized comparison between definitive chemoradiotherapy and radical surgery in patients with T(2-3)N(any) M(0) squamous cell carcinoma of the esophagus. Int J Radiat Oncol Biol Phys 57:425-433
9. Murakami M, Kuroda Y, Nakajima T et al (1999) Comparison between chemoradiation protocol intended for organ preservation and conventional surgery for clinical T1-T2 esophageal carcinoma. Int J Radiat Oncol Biol Phys 45:277-284
10. Ariga H, Nemoto K, Miyazaki S et al (2009) Prospective comparison of surgery alone and chemoradiotherapy with selective surgery in resectable squamous cell carcinoma of the esophagus. Int J Radiat Oncol Biol Phys 75:348-356
11. Nishimura Y, Okuno Y, Ono K et al (1999) External-beam radiation therapy with or without high-dose-rate intraluminal brachytherapy for superficial esophageal cancer. Cancer 86:220-228
12. Sai H, Mitsumori M, Araki N et al (2005) Long-term results of definitive radiotherapy for stage I esophageal cancer. Int J Radiat Oncol Biol Phys 62:1339-1344
13. Nemoto K, Matsumoto Y, Yamakawa M et al (2000) Treatment of superficial esophageal cancer by external radiation therapy alone: results of a multi-institutional experience. Int J Radiat Oncol Biol Phys 46:921-925
14. Nemoto K, Yamada S, Hareyama M et al (2001) Radiation therapy for superficial esophageal cancer: a comparison of radiotherapy methods. Int J Radiat Oncol Biol Phys 50:639-644
15. Kato H, Sato A, Fukuda H et al (2009) A phase II trial of che-moradiotherapy for stage I esophageal squamous cell carcinoma: Japan Clinical Oncology Group Study (JCOG9708). Jpn J Clin Oncol 39:638-643
16. Murakami Y, Kenjo M, Uno T et al (2007) Results of the 1999-2001 Japanese patterns of care study for patients receiving definitive radiation therapy without surgery for esophageal cancer. Jpn J Clin Oncol 37:493-500
17. Kenjo M, Uno T, Murakami Y et al (2009) Radiation therapy for esophageal cancer in Japan: results of the Patterns of Care Study 1999-2001. Int J Radiat Oncol Biol Phys 75:357-363
18. Nishimura Y, Mitsumori M, Hiraoka M et al (2009) A randomized phase II study of cisplatin/5-FU concurrent chemoradio-therapy for esophageal cancer: short-term infusion versus protracted infusion chemotherapy (KROSG0101/JROSG021) . Radiother Oncol 92:260-265
19. Sakayauchi T, Nemoto K, Ishioka C et al (2009) Comparison of cisplatin and 5-fluorouracil chemotherapy protocols combined with concurrent radiotherapy for esophageal cancer. Jpn J Radiol 27:131-137
20. Sai H, Mitsumori M, Yamauchi C et al (2004) Concurrent che-moradiotherapy for esophageal cancer: comparison between intermittent standard-dose cisplatin with 5-fluorouracil and daily low-dose cisplatin with continuous infusion of 5-fluorouracil. Int J Clin Oncol 9:149-153
21. Yamada K, Murakami M, Okamoto Y et al (2006) Treatment results of chemoradiotherapy for clinical stage I (T1N0M0) esophageal cancer. Int J Radiat Oncol Biol Phys 64:1106-1111
22. Sasamoto R, Sakai K, Inakoshi H et al (2007) Long-term results of chemoradiotherapy for locally advanced esophageal cancer, using daily low-dose 5-fluorouracil and cis-diammine-dichloro-platinum (CDDP). Int J Clin Oncol 12:25-30
23. Nemoto K, Matsushita H, Ogawa Y et al (2003) Radiation therapy combined with cis-diammine-glycolatoplatinum (Nedaplatin) and 5-fluorouracil for untreated and recurrent esophageal cancer. Am J Clin Oncol 26:46-49
24. Ozawa S, Tachimori Y, Baba H et al (2010) Comprehensive registry of esophageal cancer in Japan, 2002. Esophagus 7:7-22
25. Akagi Y, Hirokawa Y, Kagemoto M et al (1999) Optimum fractionation for high-dose-rate endoesophageal brachytherapy following external irradiation of early stage esophageal cancer. Int J Radiat Oncol Biol Phys 43:525-530
26. Fujita H, Ozawa S, Kuwano H et al (2010) Esophagectomy for cancer: clinical concerns support centralization operations within the larger hospitals. Dis Esophagus 23:145-152
27. Ishikura S, Nihei K, Ohtsu A et al (2003) Long-term toxicity after definitive chemoradiotherapy for squamous cell carcinoma of the thoracic esophagus. J Clin Oncol 21:2697-2702